CUE - Cue Biopharma, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/12/2019
30/12/2018
30/12/2017
30/12/2016
Total revenue
3,458
3,458
1,143
0
0
Operating expenses
Research development
27,487
27,487
28,544
18,900
5,688
Selling general and administrative
12,740
12,740
11,295
4,334
1,970
Total operating expenses
40,228
40,228
39,839
23,234
7,658
Operating income or loss
-36,769
-36,769
-38,697
-23,234
-7,658
Total other income/expenses net
64
64
165
-
-
Income before tax
-36,286
-36,286
-38,155
-23,234
-7,658
Income tax expense
413
413
825
-
-
Income from continuing operations
-36,699
-36,699
-38,980
-23,234
-7,658
Net income
-36,699
-36,699
-38,980
-23,234
-7,658
Net income available to common shareholders
-36,699
-36,699
-38,980
-23,234
-7,658
EBITDA
-
-31,604
-37,937
-22,814
-7,456